We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Monitoring Arrhythmia Patients (IMPACT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00919568
First Posted: June 12, 2009
Last Update Posted: February 4, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Corventis, Inc.
  Purpose
Prospective, multicenter, non-randomized study to determine the performance of NUVANT Mobile Cardiac Telemetry system in arrhythmia detection.

Condition
Arrhythmias

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Arrhythmia Detection With Adherent Patient Monitoring

Further study details as provided by Corventis, Inc.:

Enrollment: 28
Study Start Date: June 2009
Study Completion Date: November 2009
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Detailed Description:
Arrhythmia patients will be externally monitored. The collected information will be used to evaluate the NUVANT MCT system.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Remote cardiac monitoring
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Patients undergoing remote ambulatory electrocardiographic monitoring

Exclusion Criteria:

  • Is participating in another clinical study that may confound the results of this study
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00919568


Locations
United States, Ohio
Dr. Bedi
Steubenville, Ohio, United States, 43952
Sponsors and Collaborators
Corventis, Inc.
Investigators
Study Director: Imad Libbus, PhD Corventis, Inc.
  More Information

Responsible Party: Madhuri Bhat, VP Clinical and Regulatory affairs, Corventis
ClinicalTrials.gov Identifier: NCT00919568     History of Changes
Other Study ID Numbers: COR-2009-005
First Submitted: June 10, 2009
First Posted: June 12, 2009
Last Update Posted: February 4, 2010
Last Verified: February 2010